Two new orange–red thermally activated delayed fluorescence (TADF) materials, PzTDBA and PzDBA, are reported. These materials are designed based on the acceptor–donor–acceptor (A–D–A) configuration, containing rigid boron acceptors and dihydrophenazine donor moieties. These materials exhibit a small ΔEST of 0.05–0.06 eV, photoluminescence quantum yield (PLQY) as high as near unity, and short delayed exciton lifetime (τd) of less than 2.63 µs in 5 wt% doped film. Further, these materials show a high reverse intersystem crossing rate (krisc) on the order of 106 s−1. The TADF devices fabricated with 5 wt% PzTDBA and PzDBA as emitting dopants show maximum EQE of 30.3% and 21.8% with extremely low roll‐off of 3.6% and 3.2% at 1000 cd m−2 and electroluminescence (EL) maxima at 576 nm and 595 nm, respectively. The low roll‐off character of these materials is analyzed by using a roll‐off model and the exciton annihilation quenching rates are found to be suppressed by the fast krisc and short delayed exciton lifetime. These devices show operating device lifetimes (LT50) of 159 and 193 h at 1000 cd m−2 for PzTDBA and PzDBA, respectively. The high efficiency and low roll‐off of these materials are attributed to the good electronic properties originatng from the A–D–A molecular configuration.
NM's theory of the AIConard-Brissonneau experiment to determine domain wall specific surface energies yo by observing the catastrophic torsional distortion of 180" domain walls that span a monocrystalline platelet carrying a current density I is reviewed. It is shown that when I> 0.924 yo/JLZ ( J is the saturation polarisation of the platelet
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.